Skip to main content
. 2023 Apr 21;11:1125994. doi: 10.3389/fped.2023.1125994

Table 1.

Demographic characteristics, features at CVID onset and diagnosis are detailed.

Overall CVID cohort (N = 73) Pediatric-onset (N = 44) Adult-onset (N = 29)
Demographic Characteristics Mean SD Mean SD Mean SD p
Age at the latest follow-up 38.4 16.59 42.9 13.45 47.4 12.89 0.213
Age at onset 17.3 13.84 10.3 6.68 30.8 11.29 <0.001
Age at diagnosis 28.4 16.00 31.6 12.17 38.9 12.59 0.041
Diagnostic delay 11.5 11.71 21.7 13.76 8.2 7.76 <0.001
Follow up time 10.0 8.17 11.2 9.45 8.6 7.67 0.279
Time of disease 21.5 13.86 33.0 15.38 16.8 10.23 <0.001
Characteristics at CVID onset N % N % N % p
Immune Dysregulation 31.0 42.47 16.0 36.36 15.0 51.72 0.231
Infections 65.0 89.04 38.0 86.36 27.0 93.10 0.465
Malignancy 0.0 0.00 0.0 0.00 0.0 0.00 NA
Syndromic Features 3.0 4.11 3.0 6.82 0.0 0.00 0.272
Other Symptoms 5.0 6.85 3.0 6.82 2.0 6.90 1
No Symptoms 2.0 2.74 2.0 4.55 0.0 0.00 0.514
Hypogammaglobulinemia 2.0 2.74 2.0 4.55 0.0 0.00 0.514
Characteristics at CVID diagnosis N % N % N % p
Recurrent respiratory infections 65 89.0 42 95.5 24 82.8 0.252
Failure to thrive (infancy) 5 6.8 5 11.4 0 0.0 0.51
Recurrent pyogenic infections 6 8.2 2 4.5 4 13.8 0.207
Unusual infections 7 9.6 4 9.1 3 10.3 ns
Same pathogen recurrent infections 7 9.6 5 11.4 2 6.9 0.696
Autoimmunity, autoinflammation, and lymphoid proliferation 30 41.1 16 36.4 14 48.3 0.34
Pneumonia 44 60.3 26 59.1 18 62.1 ns
Meningitis 6 8.2 3 6.8 3 10.3 0.676
Upper respiratory airways recurrent infections 64 87.7 41 93.2 23 79.3 0.142
Lower respiratory airways recurrent infections 40 54.8 22 50.0 18 62.1 0.345
Gastrointestinal recurrent infections 25 34.2 16 36.4 9 31.0 0.802
Urinary tract infections 14 19.2 6 13.6 8 27.6 0.223
Skin recurrent infections 6 8.2 3 6.8 3 10.3 0.676
Other recurrent infections 4 5.5 2 4.5 2 6.9 ns
Unusual viral infections 11 15.1 7 15.9 4 13.8 ns
Unusual opportunistic infections 4 5.5 2 4.5 2 6.9 ns
Unusual parasitic infections 1 1.4 0 0.0 1 3.4 0.394
Bronchiectasis 31 43.1 18 41.9 13 44.8 0.813
Enteropathy 9 12.3 4 9.1 5 17.2 0.469
Lymphocytic colitis 9 12.3 4 9.1 5 17.2 0.469
Hepatomegaly 16 21.9 8 18.2 8 27.6 0.394
Splenomegaly 38 52.1 21 47.7 17 58.6 0.474
Liver disease 5 6.8 3 6.8 2 6.9 ns
Pulmonary disease 29 39.7 18 40.9 11 37.9 ns
GLILD 1 1.4 0 0.0 1 3.4 0.397
Other organ diseases 10 13.7 7 15.9 3 10.3 0.73
Hypothyroidism 3 4.1 2 4.5 1 3.4 ns
Chronic diarrhea 5 6.8 4 9.1 1 3.4 0.642
Autoimmune cytopenia 17 23.3 10 22.7 7 24.1 ns
Autoimmune hemolytic anemia 8 11.0 6 13.6 2 6.9 0.465
Autoimmune neutropenia 3 4.1 1 2.3 2 6.9 0.559
Immune Thrombocytopenia 17 23.3 10 22.7 7 24.1 ns
Evans syndrome 9 12.3 6 13.6 3 10.3 ns
Other organ autoimmunity 13 17.8 6 13.6 7 24.1 0.35
Thyroiditis 7 9.6 3 6.8 4 13.8 0.425
Atrophic gastritis 1 1.4 1 2.3 0 0.0 ns
Vitiligo 2 2.7 2 4.5 0 0.0 0.514
Psoriasis 3 4.1 1 2.3 2 6.9 0.559
History of malignancy 1 1.4 0 0.0 1 3.4 0.397
Lymphoid Nodular Hyperplasia 7 9.6 4 9.1 3 10.3 ns
Granulomas 3 4.1 1 2.3 2 6.9 0.559
Celiac disease 5 6.8 2 4.5 3 10.3 0.38
Allergy 16 22.2 12 27.9 4 13.8 0.248
Persistent HCV viremia 0 0.0 0 0.0 0 0.0 na
Persistent HIV viremia 0 0.0 0 0.0 0 0.0 na
Persistent EBV viremia 3 4.8 1 2.6 2 8.0 0.557
Persistent CMV viremia 1 1.6 1 2.8 0 0.0 ns
Pathologic HRCT 51 79.7 32 82.1 19 76.0 0.751
Pathologic endoscopy 23 63.9 14 77.8 9 50.0 0.164